Red Maple Trials provides specialty services in allergy, asthma and immunology clinical research. Our next generation clinical trial facilities are capable of executing on Phase 1 through 4 studies, and our experienced team provides site management services in order to fulfill the challenging demands of our biopharmaceutical partners. Our Allergen Challenge Theatre (TM) is a 100 person next generation environmental exposure unit that delivers predictability, stability, and a high degree of automation and control. RMT has also built two state-of-the-art Naturalistic Exposure Chambers (TM) that have been specifically designed for specialized human cat allergen exposure studies. Our facilities are strategically located in a dense, multi-cultural national capital, and leverages our deep investigator network that spans a population catchment of 8 million total residents. Extensive Phase I Unit Capabilities: - 15 bed facility with overnight capabilities - Fully trained staff to handle overnight and 24 hour monitoring - Specialized equipment and trained staff - Spirometry and PFT - Pharmacokinetic testing - Bioequivalency / Bioavailability - Nasal lavage and Sputum analysis - Full SOP Catalogue for emergency, adverse event preparedness, sample and document storage Specific CRO services that we provide or manage on behalf of our sponsors include: - Clinical trial coordination and end to end site management - Patient recruitment and logistics management - Clinical trial protocol design - Regulatory guidance and compliance - Informed consent and submissions - Medical writing and submissions for publication - Data management - Biostatistics For more information, please visit our website www.redmapletrials.com